-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Ministry of Commerce issued a document to cultivate 5-10 giant pharmacies with annual sales of 50 billion yuan by 2025
Ministry of Commerce issued a document to cultivate 5-10 50 billion pharmacies
Ministry of Commerce issued a document to cultivate 5-10 50 billion pharmaciesOn October 28, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-Quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" Period" (hereinafter referred to as the "Opinions")
According to the target plan of the "Opinions", by 2025, the pharmaceutical distribution industry will meet the needs of people's health in the new stage of development in China, and the modern pharmaceutical distribution system featuring innovation, technology empowerment, coverage of urban and rural areas, balanced layout, coordinated development, and safety and convenience will be more complete.
At the same time, cultivate 1-3 large-scale digital and comprehensive drug distribution companies with a value of more than 500 billion yuan, 5-10 with a value of more than 100 billion yuan, and 5-10 specialized and diversified drug retail chains with a value of more than 50 billion yuan.
By 2025, the annual sales of the top 100 pharmaceutical wholesale companies will account for more than 98% of the total pharmaceutical wholesale market; the annual sales of the top 100 pharmaceutical retail companies will account for more than 65% of the total pharmaceutical retail market; and the drug retail chain rate will be close to 70%
Optimize the layout and encourage the characteristic development of pharmacies
Optimize the layout and encourage the characteristic development of pharmaciesAt the same time, the "Opinions" also talked about the need to improve the function of urban and rural drug distribution and focus on improving the level of drug distribution
In terms of improving the circulation function of urban and rural medicines, the "Opinions" require three points:
First, optimize the industry layout
Second, speed up the construction of rural drug distribution networks
Third, improve the city's drug circulation service capabilities
In terms of improving the energy level of drug circulation, two things must be done:
One is to develop modern pharmaceutical logistics
The second is to develop a modern green smart supply chain
Three development directions, retail pharmacies are well received
Three development directions, retail pharmacies are well receivedIn addition, the "Opinions" also provides three directions for the development of retail pharmacies:
First, steadily develop digital drug circulation
Promote the "Internet + drug circulation": accelerate the application of 5G networks, big data and other technologies, optimize the traditional mode of drug circulation, and achieve iterative upgrades of elements, structures, processes, and services
Develop new business formats and new models: support the integrated development of pharmaceutical distribution companies and e-commerce platforms, develop smart supply chains, smart logistics, smart pharmacies, and other new forms, promote new retail models such as "online order-in stores" and "online-order stores delivery", and guide Online and offline standardized development
Second, continue to optimize the structure of the circulation industry
Cultivate and strengthen the circulation main body: support the cross-regional and cross-ownership merger and reorganization of drug circulation enterprises, and cultivate large-scale modern drug circulation backbone enterprises
Third, promote foreign exchanges and cooperation
Actively carry out international exchanges and cooperation: Promote pharmaceutical distribution companies to face both international and domestic markets, and carry out various forms of international exchanges and investment cooperation
Vigorously develop the foreign trade of Chinese medicine: support the overseas registration of Chinese medicine products, actively participate in the research and formulation of international plans and standards, and expand the scale of the international market for Chinese medicine products